3
Announcements
Trials
Browse
Landscape
Phase
Phase 2
2
Status
Not yet recruiting
2
Withdrawn
1
Sponsor Class
OTHER
2
Study Type
Interventional
2
Sponsor
Cancer Type
Breast
2
Conditions
Carcinoma, Non-Small-Cell Lung
134
Breast Neoplasms
94
Colorectal Neoplasms
65
Carcinoma, Hepatocellular
57
Squamous Cell Carcinoma of Head and Neck
48
Stomach Neoplasms
46
Lung Neoplasms
45
Triple Negative Breast Neoplasms
43
Prostatic Neoplasms
43
Leukemia, Myeloid, Acute
43
Small Cell Lung Carcinoma
41
Uterine Cervical Neoplasms
40
Rectal Neoplasms
37
Neoplasms
31
Pancreatic Neoplasms
30
Recurrence
29
Neoplasm Metastasis
29
Esophageal Squamous Cell Carcinoma
25
Esophageal Neoplasms
24
Ovarian Neoplasms
23
Nasopharyngeal Carcinoma
21
Brain Neoplasms
21
Melanoma
20
Lymphoma, Large B-Cell, Diffuse
20
Colonic Neoplasms
20
Carcinoma, Renal Cell
20
Head and Neck Neoplasms
19
Endometrial Neoplasms
19
Multiple Myeloma
18
Biliary Tract Neoplasms
18
Interventions
trastuzumab deruxtecan
2
neratinib
1
Bevacizumab
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
2 trials
Recent
Start date
Enrollment
Phase 2
×
Not yet recruiting
×
Breast Cancer With Brain Metastasis
×
Clear all
NCT07152782
2025-09-03
THUNDER
Fudan University
Phase 2
Not yet recruiting
202 enrolled
NCT07150208
2025-09-02
THUMB
Fudan University
Phase 2
Not yet recruiting
140 enrolled